首页 | 本学科首页   官方微博 | 高级检索  
     

吡柔比星与阿霉素对心脏毒性的临床比较
引用本文:刘永生. 吡柔比星与阿霉素对心脏毒性的临床比较[J]. 实用临床医学(江西), 2001, 2(4): 1
作者姓名:刘永生
作者单位:江西省瑞金市人民医院内科 江西瑞金342500;
摘    要:
目的 :比较吡柔比星和阿霉素的临床心脏毒性。方法 :采用临床体检和心电图记录的方法 ,观察分别用含吡柔比星和含阿霉素方案化疗的 86例肿瘤病人的心脏毒性的发生率。结果 :无论是累积剂量小于 45 0mg组还是大于或等于 45 0mg组中 ,采用含阿霉素方案化疗的病人的心脏毒性的发生

关 键 词:吡柔比星  心脏毒性  阿霉素  

Comparison between Cardiotoxicities of Pirarubicin and Adriamycin
Liu Yong sheng. Comparison between Cardiotoxicities of Pirarubicin and Adriamycin[J]. Practical Clinical Medicine, 2001, 2(4): 1
Authors:Liu Yong sheng
Abstract:
Objectives: To compare the cardiotoxicity of pirarubicin with that of adriamycin. Methods: Cardiotoxic actions were evaluated with physical examination and electrocardiographic parameters in 86 patients with cancer after chemotherapy with THP combination or ADM combination. Results: Cardiotoxicity occurred more frequently in the patients treated with combination containing ADM than those treated with combination containing THP. Conclusion: THP has less cardiotoxicity than ADM.
Keywords:pirarubicin  adriamycin  cardiotoxicity
本文献已被 CNKI 等数据库收录!
点击此处可从《实用临床医学(江西)》浏览原始摘要信息
点击此处可从《实用临床医学(江西)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号